Antiemetics Global Market 2018: Key Players – Abbott Laboratories, Daiichi Sankyo Company, Ltd., Merck & Co., Novartis AG, Sanofi Aventis

Antiemetics Industry

Description

Wiseguyreports.Com Adds “Antiemetics -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database

Emesis is a devastating adverse effect of surgery, poisoning, chemotherapy, vestibular imbalance, medication, radiotherapy and during pregnancy. Emesis itself is not a disease but an indication of a stressed physiological condition. During the last decades, extraordinary technological advances have made innovations in most of the disease therapies, including cancer therapies, which is the most common cause of emesis.

Antiemetic drug market is population driven and mostly depends on the number of chemotherapy and radiation therapy sessions performed in specific geographic regions that have high cancer burden and utilize chemotherapy and radiation therapy for cancer treatment. Antiemetics are used to suppress nausea and vomiting associated with CINV, PINV, NVP, RINV, motion sickness and vestibular sickness. 5-HT3 receptor antagonists and NK1 receptor antagonists are the most frequently used antiemetic drug categories.

The global market for antiemetics in 2017 was nearly REDACTED and is expected to reach REDACTED during the forecast period of 2018-2023. The 5-HT3 receptor antagonist market accounts for the largest market share (REDACTED) of the global antiemetic market. NK1 receptor antagonists are the second largest antiemetic drug segment. NK1 receptor antagonists antiemetic drug market is expected to increase at the rate of REDACTED CAGR, thanks to the approval of the U.S. Food and Drug Administration(FDA), commercial launch of new drug candidates, and the existing pipeline which is likely to hit the market in by 2023. Anticholinergics and benzodiazepines are the smallest antiemetic market segments, accounting for approximately REDACTED of the overall market share.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3294459-antiemetics-technologies-and-global-markets

Based on applications CINV contribution to antiemetic drug was approximately REDACTED in 2017. Motion sickness and vestibular disorder is the second largest segment by application, accounting for approximately REDACTED in 2017. The CINV market is expected to rise by a CAGR REDACTED during the forecast period. North America is the leading contributor to antiemetic drug market, accounting for about REDACTED of the antiemetic drug market. Middle East and Africa antiemetic market is expected to grow at the highest rate (REDACTED CAGR) during the forecast period.

Report Scope

The report details the antiemetic drug market. The analysis highlights current and future market potential for antiemetic drug and presents a detailed review of pipeline drugs, blockbuster drugs, and challenges to market growth. The report also examines disease burden, regulatory environment, novel technologies, and market projections to 2023. Antiemetic drug market drivers, trends and potential regional market opportunities are also covered in this report.

The report details market shares of antiemetic drug class (5-HT3 receptor antagonists, dopamine antagonists, steroid-corticosteroids, benzodiazepines, NK1 receptor antagonist, antihistamines, cannabinoids, and anticholinergic) and geographic market segmentation of overall market; global market share by applications, with special emphasis on developed and underdeveloped geographic regions. For market estimates, data has been provided for 2017, as base year, 2018 and forecast for 2023.

Report Includes

- 21 data tables and 15 additional tables 
- Country specific data and analysis for United States, Canada, Mexico, France, Germany, UK, China, India, Japan, and Middle East and Africa 
- An overview about current and future market potential for antiemetic drugs with special focus on competitive environment, pipeline drugs and blockbuster drugs 
- Coverage of disease burden, regulatory environment, and novel technologies in the antiemetic drugs market 
- Detailed description about vestibular disorder and increasing demand of innovative technology for treatment 
- Exploration of the causes of emesis, usage of antiemetics and the types of products available to treat nausea and vomiting by each application segment 
- Information about the launching of new drugs in each antiemetic drug class such as 5 HT3 receptor antagonists, dopamine antagonists, NK1 receptor antagonist, and so forth 
- Detailed company profiles of major players in the market, including Abbott Laboratories, Daiichi Sankyo Company, Ltd., Merck & Co., Novartis AG, Sanofi Aventis and Teva Pharmaceutical Industries Ltd.

Leave a Query @ https://www.wiseguyreports.com/enquiry/3294459-antiemetics-technologies-and-global-markets

Table of Contents 

Chapter 1 Introduction 
Chapter 2 Summary and Highlights 
Chapter 3 Overview 
Chapter 4 Market and Technology Background 
Chapter 5 Market Breakdown by Drug Class 
Chapter 6 Market Breakdown by Application 
Chapter 7 Market Breakdown by Region 
Chapter 8 Patent Review/New Developments 
Chapter 9 Pipeline Analysis 
Chapter 10 Regulatory Landscape 
Chapter 11 Company Profiles 
ABBOTT LABORATORIES 
Overview 
Financial Information 
Products and Services 
Development and Strategies 
ASTELLAS PHARMA INC. 
Overview 
Financial Information 
Products and Services 
Development and Strategies 
APHIOS CORP. 
Overview 
AUROBINDO PHARMA 
Overview 
Financial Information 
Products and Services 
DAIICHI SANKYO COMPANY LTD. 
Overview 
Financial Information 
Product and Services 
Development and Strategies 
EISAI CO., INC. 
Overview 
Financial Information 
Products and Services 
GLAXOSMITHKLINE PLC 
Overview 
Financial Information 
Products and Services 
HELSINN HEALTHCARE SA 
Overview 
Products and Services 
Key Developments and Strategies 
HERON THERAPEUTICS, INC. 
Overview 
Financials 
Products and Services 
IPCA LABORATORIES, LTD. 
Overview 
KYOWA HAKKO KIRIN PHARMA, INC. 
Overview 
Financials 
MERCK & CO., INC. 
Overview 
Financial Information 
Products and Services 
NOVARTIS AG 
Overview 
Financial Information 
F. HOFFMANN-LA ROCHE AG 
Overview 
Financial Information 
Products and Services 
SANOFI AVENTIS 
Overview 
Financial Information 
Products and Services 
TESARO, INC. 
Overview 
Financial Information 
Products and Services 
Development and strategies 
TEVA PHARMACEUTICAL INDUSTRIES LTD. 
Overview 
Financial Information 
Product and Services 
Development and Strategies 
Chapter 12 Appendix: Abbreviations

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3294459

Continued...                       

 

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

About Us:
Wise Guy Reports Is Part Of The Wise Guy Consultants Pvt. Ltd. And Offers Premium Progressive Statistical Surveying, Market Research Reports, Analysis & Forecast Data For Industries And Governments Around The Globe. Wise Guy Reports Features An Exhaustive List Of Market Research Reports From Hundreds Of Publishers Worldwide. We Boast A Database Spanning Virtually Every Market Category And An Even More Comprehensive Collection Of Market Research Reports Under These Categories And Sub-Categories.

Addres:
Wise Guy Research Consultants Pvt Ltd
Pune – 411028
Maharashtra, Global
Ph: +91 841 198 5042
https://www.wiseguyreports.com

This release was published on openPR.